[Enhanced activity of the protective factors in patients with suppurative surgical infection using interferon preparations].
Administration of leukocytic interferon to patients with sepsis and purulent resorptive fever resulted in a reliable increase in the indices of the host protective factors with respect to the infections. Addition of interferon to the surgical and antibacterial treatment promoted a decrease in the periods providing the clinical effect to 19.8 days against 43.8 days in the treatment without interferon.
D002270:Carbuncle / Q000276:immunology / Q000628:therapy; D003131:Combined Modality Therapy; D005260:Female; D005597:Fractures, Open / Q000150:complications / Q000276:immunology / Q000628:therapy; D006801:Humans; D007370:Interferon Type I / Q000627:therapeutic use*; D008413:Mastitis / Q000276:immunology / Q000628:therapy; D008875:Middle Aged; D011961:Receptors, Fc / Q000032:analysis; D012397:Rosette Formation; D013601:T-Lymphocytes / Q000276:immunology; D014946:Wound Infection / Q000209:etiology / Q000276:immunology / Q000628:therapy*
D007370:Interferon Type I; D011961:Receptors, Fc
Povyshenie aktivnosti faktorov zashchity u bol'nykh s gnoĭnoĭ khirurgicheskoĭ infektsieĭ pri primenenii preparatov interferona.